シングルセル解析市場は、ゲノミクス、トランスクリプトミクス、プロテオミクスの進歩により、15.9%のCAGRで成長し、162億ドルに達すると予想されます。がん研究、免疫学、神経科学への応用が重要な推進要因であり、シングルセルRNAシーケンシングやフローサイトメトリーなどの技術の需要が高まっています。さらに、業界はカスタマイズされた医療や創薬イニシアチブの進歩から恩恵を受けています。
								
						目次
						
	Table of Content
	1. Executive Summary
	
	1.1. Regional Market Share
	1.2. Business Trends
	1.3. Single Cell Analysis Market: COVID-19 Outbreak
	1.4. Regional Trends
	1.5. Segmentation Snapshot
	2. Research Methodology
	
	2.1. Research Objective
	2.2. Research Approach
	2.3. Data Sourcing and Methodology
	2.4. Primary Research
	2.5. Secondary Research
	2.5.1. Paid Sources
	2.5.2. Public Sources
	2.6. Market Size Estimation and Data Triangulation
	3. Market Characteristics
	
	3.1. Market Definition
	3.2. Single Cell Analysis Market: COVID-19 Impact
	3.3. Key Segmentations
	3.4. Key Developments
	3.5. Allied Industry Data
	4. Single Cell Analysis Market - Industry Insights
	
	4.1. Industry Segmentation
	4.2. COVID-19 overview on world economy
	4.3. Industry ecosystem Channel analysis
	4.4. Innovation & Sustainability
	5. Macroeconomic Indicators
	6. Recent Developments
	7. Market Dynamics
	
	7.1. Introduction
	7.2. Growth Drivers
	7.3. Market Opportunities
	7.4. Market Restraints
	7.5. Market Trends
	8. Risk Analysis
	9. Market Analysis
	
	9.1. Porters Five Forces
	9.2. PEST Analysis
	9.2.1. Political
	9.2.2. Economic
	9.2.3. Social
	9.2.4. Technological
	10. Single Cell Analysis Market
	
	10.1. Overview
	10.2. Historical Analysis (2019-2021)
	10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
	11. Single Cell Analysis Market Size & Forecast 2022A-2032F
	
	11.1. Overview
	11.2. Key Findings
	11.3. Market Segmentation
	11.3.1. By Product
	11.3.1.1. Consumables
	11.3.1.1.1. By Value (USD Million) 2022-2032F
	11.3.1.1.2. Market Share (%) 2022-2032F
	11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
	11.3.1.2. Instruments
	11.3.1.2.1. By Value (USD Million) 2022-2032F
	11.3.1.2.2. Market Share (%) 2022-2032F
	11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
	11.3.2. By Application
	11.3.2.1. Cancer
	11.3.2.1.1. By Value (USD Million) 2022-2032F
	11.3.2.1.2. Market Share (%) 2022-2032F
	11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
	11.3.2.2. Immunology
	11.3.2.2.1. By Value (USD Million) 2022-2032F
	11.3.2.2.2. Market Share (%) 2022-2032F
	11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
	11.3.2.3. Neurology
	11.3.2.3.1. By Value (USD Million) 2022-2032F
	11.3.2.3.2. Market Share (%) 2022-2032F
	11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
	11.3.2.4. Stem Cell
	11.3.2.4.1. By Value (USD Million) 2022-2032F
	11.3.2.4.2. Market Share (%) 2022-2032F
	11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
	11.3.2.5. Non-invasive prenatal diagnosis
	11.3.2.5.1. By Value (USD Million) 2022-2032F
	11.3.2.5.2. Market Share (%) 2022-2032F
	11.3.2.5.3. Y-o-Y Growth (%) 2022-2032F
	11.3.2.6. Others
	11.3.2.6.1. By Value (USD Million) 2022-2032F
	11.3.2.6.2. Market Share (%) 2022-2032F
	11.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
	11.3.3. By End Users
	11.3.3.1Academic & Research laboratories
	11.3.3.1.1 By Value (USD Million) 2022-2032F
	11.3.3.1.2Market Share (%) 2022-2032F
	11.3.3.1.3Y-o-Y Growth (%) 2022-2032F
	11.3.3.2Biotechnology & Pharmaceutical companies
	11.3.3.2.1By Value (USD Million) 2022-2032F
	11.3.3.2.2 Market Share (%) 2022-2032F
	11.3.3.3.1Y-o-Y Growth (%) 2022-2032F
	11.3.3.3Hospitals and Diagnostic laboratories
	11.3.3.3.1By Value (USD Million) 2022-2032F
	11.3.4.1.2Market Share (%) 2022-2032F
	11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
	11.3.3.4Others
	11.3.3.4.1By Value (USD Million) 2022-2032F
	11.3.3.4.2 Market Share (%) 2022-2032F
	11.3.3.4.3 Y-o-Y Growth (%) 2022-2032F
	11.3.4By Cell Type
	11.3.4.1 Human
	11.3.4.1.1 By Value (USD Million) 2022-2032F
	11.3.4.1.2Market Share (%) 2022-2032F
	11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
	11.3.4.2Animal
	11.3.4.2.1By Value (USD Million) 2022-2032F
	11.3.4.2.2 Market Share (%) 2022-2032F
	11.3.4.2.3 Y-o-Y Growth (%) 2022-2032F
	11.3.4.3Microbial
	11.3.4.3.1By Value (USD Million) 2022-2032F
	11.3.4.3.2 Market Share (%) 2022-2032F
	11.3.4.3.3 Y-o-Y Growth (%) 2022-2032F
	12. North America Single Cell Analysis Market Size & Forecast 2022A-2032F
	
	12.1. Overview
	12.2. Key Findings
	12.3. Market Segmentation
	12.3.1. By Product
	12.3.2. By Application
	12.3.3. By End Users
	12.3.4. By Cell Type
	12.4. Country
	12.4.1. United States
	12.4.2. Canada
	13. Europe Single Cell Analysis Market Size & Forecast 2022A-2032F
	
	13.1. Overview
	13.2. Key Findings
	13.3. Market Segmentation
	13.3.1. By Product
	13.3.2. By Application
	13.3.3. By End Users
	13.3.4. By Cell Type
	13.4. Country
	13.4.1. Germany
	13.4.2. United Kingdom
	13.4.3. France
	13.4.4. Italy
	13.4.5. Spain
	13.4.6. Russia
	13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
	14. Asia-Pacific Single Cell Analysis Market Size & Forecast 2022A-2032F
	
	14.1. Overview
	14.2. Key Findings
	14.3. Market Segmentation
	14.3.1. By Product
	14.3.2. By Application
	14.3.3. By End Users
	14.3.4. By Cell Type
	14.4. Country
	14.4.1. India
	14.4.2. China
	14.4.3. South Korea
	14.4.4. Japan
	14.4.5. Rest of APAC
	15. Middle East and Africa Single Cell Analysis Market Size & Forecast 2022A-2032F
	
	15.1. Overview
	15.2. Key Findings
	15.3. Market Segmentation
	15.3.1. By Product
	15.3.2. By Application
	15.3.3. By End Users
	15.3.4. By Cell Type
	15.4. Country
	15.4.1. Israel
	15.4.2. GCC
	15.4.3. North Africa
	15.4.4. South Africa
	15.4.5. Rest of Middle East and Africa
	16. Latin America Single Cell Analysis Market Size & Forecast 2022A-2032F
	
	16.1. Overview
	16.2. Key Findings
	16.3. Market Segmentation
	16.3.1. By Product
	16.3.2. By Application
	16.3.3. By End Users
	16.3.4. By Cell Type
	16.4. Country
	16.4.1. Mexico
	16.4.2. Brazil
	16.4.3. Rest of Latin America
	17. Competitive Landscape
	
	17.1. Company market share, 2021
	17.2. Key player overview
	17.3. Key stakeholders
	18. Company Profiles
	
	18.1. Illumina Inc.
	18.1.1. Company Overview
	18.1.2. Financial Overview
	18.1.3. Key Product; Analysis
	18.1.4. Company Assessment
	18.1.4.1. Product Portfolio
	18.1.4.2. Key Clients
	18.1.4.3. Market Share
	18.1.4.4. Recent News & Development (Last 3 Yrs.)
	18.1.4.5. Executive Team
	18.2. 10x Genomics Inc.
	18.3. Fluidigm Corporation
	18.4. BD Biosciences
	18.5. Mission Bio
	18.6. NanoString Technologies
	18.7. Thermo Fisher Scientific
	18.8. Bio-Rad Laboratories
	18.9. Qiagen
	18.10. Agilent Technologies
	18.11. Miltenyi Biotec
	18.12. Dolomite Bio
	18.13. Bio-Techne Corporation
	18.14. Zeiss Group
	18.15. Abcam plc
	18.16. Other Prominent Players
	19. Appendix
	20. Consultant Recommendation